Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Following HREC rejection, NeuroScientific Biopharma bounces back with new patent for EmtinB to treat multiple sclerosis
    • News

    Following HREC rejection, NeuroScientific Biopharma bounces back with new patent for EmtinB to treat multiple sclerosis

    Drug development company NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) is not ready to give up on EmtinB, its trademark drug that didn’t make it past the Human Research Ethics Committee (HREC) and resulted in the Company’s previous CEO resigning. Remaining undeterred, it has filed a new patent, entitled “Neuroprotective compositions and methods”, that will use a

    Read More
    Public
  • Major shareholder calls for Jag Sanger’s removal from The Market Herald amid losses
    • News

    Major shareholder calls for Jag Sanger’s removal from The Market Herald amid losses

    In a keyboard warrior popularity contest between HotCopper and the AFR, the former would probably win. And while Managing Director of The Market Herald (ASX: TMH), Jag Sanger, is nearly aggressively proud of that, investors aren’t so impressed. Recently, the Company’s poor financials and questionable growth strategy have led to calls for Sanger’s removal. The

    Read More
    Public
  • VIP ceases glove production as demand falls, after tooting their own horn for two years
    • News

    VIP ceases glove production as demand falls, after tooting their own horn for two years

    Remember when Frank Sinatra caught a cold and couldn’t perform? He might as well have thrown in the towel and joined the crowd outside Nat King Cole’s venue; his voice was his identity. The only difference between Sinatra and nitrile glove manufacturer VIP Gloves (ASX: VIP) is that Sinatra had a personality beyond singing. VIP

    Read More
    Public
  • 41yr old successfully convinces soccer mates he understands offside rule
    • Satire

    41yr old successfully convinces soccer mates he understands offside rule

    41 year old Hugh Honey has had perhaps the biggest win of the FIFA World Cup so far.  After being peer pressured by his soccer-loving mates into attending the Australia vs Denmark clash live at Federation Square in Melbourne, Honey was determined to walk away feeling like he belonged. Despite more commonly remarking that the

    Read More
    Public
  • EchoIQ’s EchoSolv AI tech detects severe aortic stenosis with accuracy
    • News

    EchoIQ’s EchoSolv AI tech detects severe aortic stenosis with accuracy

    The team at Echo IQ (ASX: EIQ), who have been excelling AI medical tech, is happy to say that their tech can finally detect and diagnose the early stages of severe aortic stenosis (heart disease) following positive results from the clinical study conducted with Beth Israel Deaconess Medical Center (BIDMC), the world-renowned teaching hospital affiliated

    Read More
    Public
  • Aus Department of Defence signs $27 million order for AeroVironment drones from XTEK
    • News

    Aus Department of Defence signs $27 million order for AeroVironment drones from XTEK

    How can governments minimise casualties during the war? One solution is to send fewer people. That’s what tech, like drones, enables without compromising safety—which is probably why many countries are jumping on the bandwagon to secure some advanced drones. Just one day after it delivered an over three-million-dollar US government order, defence industry company XTEK

    Read More
    Public
  • «
  • ‹
  • 304
  • 305
  • 306
  • 307
  • 308
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.